Iterum Therapeutics requests Nasdaq hearing to appeal delisting; warns of possible wind-down

Iterum Therapeutics plc

On March 3, 2026, Iterum requested a hearing before Nasdaq Hearings Panel to appeal delisting for failure to maintain $1.00 bid price.
Hearing request automatically stays suspension scheduled for March 5, 2026, pending the hearing and any extension.
Company also fails to meet $35M minimum market value of listed securities requirement; compliance deadline June 9, 2026.
Evaluating strategic alternatives including possible wind-down, bankruptcy, licensing or sale of assets.
Company states limited ability to raise capital; shareholders very unlikely to receive distribution in a wind-down.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-088494
form_type: 8-K
ticker: ITRMF
cik: 0001659323
company_name: Iterum Therapeutics plc
filed_at: 2026-03-03T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.790860+00:00
generated_at: 2026-05-15T22:17:42.568802+00:00
sec_items: ["8.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-088494
json_url: https://secwatch.observer/filing/0001193125-26-088494.json
markdown_url: https://secwatch.observer/filing/0001193125-26-088494.md
text_url: https://secwatch.observer/filing/0001193125-26-088494.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1659323/000119312526088494/0001193125-26-088494-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1659323/000119312526088494/itrm-20260303.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-088494

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.